1540 Journal of Natural Products, 2005, Vol. 68, No. 10
Notes
DMAP ((dimethylamino)pyridine), and 135 mg of N-hydroxy-
benzotriazole hydrate (HOBt) (Novabiochem, San Diego, CA).
A coupling efficiency close to 100% was achieved after 18 h.
The resin was washed with DMF, and the reaction product
(10) was cleaved from the resin by 1:2:7 mixtures of HOAc,
2,2,2-trifluoroethanol, and CH2Cl2 for 90 min at room tem-
perature. Product 1 (161 mg of crude peptide; 43% yield) was
purified by HPLC on a C4 column (Vydac, Hesperia, CA), using
a 0.1% TFA in H2O/MeCN gradient.
br m, H-8, H-10, NH), 5.78 (1H, s, H-14), 4.66 (1H, m, alanine
CR-H), 2.42 (3H, s, H-20), 2.10 (2H, m, H-4), 2.08 (3H, s, H-19),
1.78 (3H, s, H-18), 1.69 (2H, m, H-3), 1.55 (5H, m, H-2 and
alanine CH3), 1.11 (6H, s, H-16 and H-17); HRFABMS m/z M+
371.2465 (calcd for C23H33O3N, 371.2461).
Acknowledgment. This work was supported by grants
from the National Institutes of Health (CA49933, CA89362,
CA08748, and GM36564). We are also grateful for an NIH
Vision Training grant, EY13933-3 (to N.F.).
1H NMR (400 MHz, CDCl3) δ 6.95 (1H, dd, J ) 11 Hz, 15
Hz, 11-H), 6.71 (1H, br s, NH), 6.29-6.14 (4H, m, H-7, H-12,
H-8, and H-10), 5.75 (1H, s, H-14), 4.67 (1H, m, H-a), 4.17 (1H,
d, J ) 9 Hz, -CH2-OH), 3.82 (1H, d, J ) 9 Hz, -CH2-OH),
2.36 (3H, s, H-20), 2.06 (2H, m, H-4), 1.99 (3H, s, H-19), 1.74
(3H, s, H-18), 1.61 (2H, m, H-3), 1.48 (2H, m, H-2), 1.03 (6H,
s, H-16 and H-17); HRFABMS m/z M+ 387.2413 (calcd for
C21H3304N, 387.2409).
References and Notes
(1) Wald, G. Science 1968, 162, 230-232.
(2) Maden, M. Acta Biotheoretica 1993, 41, 425-445.
(3) Evans, R. M.; Hollenberg, S. M. Cell 1988, 52, 1-3.
(4) Petkovitch, M.; Brand, N. J.; Krust, A.; Chambon, P. Nature 1987,
330, 444-450.
(5) Blaner, W. S.; Olson, J. A. In The Retinoids: Biology, Chemistry and
Medicine, 2nd ed.; Sporn, M. B., Roberts, A. B., Goodman, D. W., Eds.;
Raven Press: Ltd: New York, 1994; pp 209-286.
(6) Buck, J.; Derguini, F.; Levi, E.; Nakanishi, K.; Hammerling, U.
Science 1991, 254, 1654-1656.
(7) Derguini, F.; Nakanishi, K.; Hammerling, U.; Chua, R.; Eppinger,
T.; Levi, E.; Buck, J. J. Biol. Chem. 1995, 270, 18875-18880.
(8) Buck, J.; Grun, F.; Derguini, F.; Chen, Y.; Kimura, S.; Noy, N.;
Hammerling, U. J. Exp. Med. 1993, 178, 675-680.
(9) Grun, F.; Noy, N.; Hammerling, U.; Buck, J. J. Biol. Chem. 1996,
271, 16135-16138.
Synthesis of N-trans-Retinoylalanine (2) (Figure 4). RA
(3) (20 mg, 0.066 mmol), EDC-HCl (37.8 mg, 0.198 mmol), and
the free base of L-alanine methyl ester (6.8 mg, 0.066 mmol)
were dissolved in 3 mL of dry CH2Cl2 and stirred for 20 min
at room temperature and then treated with DMAP (1.6 mg,
0.0132 mmol). The reaction was stirred for 4 h and then
quenched with saturated aqueous NH4Cl. The organic layer
was washed once with saturated aqueous NaHCO3 and once
with H2O and then dried over Na2SO4 and concentrated in
vacuo. The residue was purified by flash column chromatog-
raphy (SiO2, 4:1 hexanes-EtOAc). The isolated N-trans-
retinoylalanine methyl ester (11) was redissolved in 4 mL of
absolute EtOH and treated with 50 mg of KOH for 3 h. The
mixture was diluted with H2O, the aqueous solution was
acidified to pH 3 with 6 N HCl, and the precipitate was
extracted with ether (3 × 10 mL). The ether layer was washed
with brine and then dried over Na2SO4. The solvent was
removed in vacuo, and the yellow solid was purified by flash
column chromatography (SiO2, 10:1 CHCl3-MeOH) to give
10.3 mg of N-trans-retinoylalanine (2) (42% yield) as yellow
crystals: 1H NMR (400 MHz, CDCl3) δ 6.98 (1H, dd, J ) 11,
15 Hz, H-11), 6.32 (1H, m, H-7), 6.25 (1H, m, H-12), 6.18 (3H,
(10) Hoyos, B.; Imam, A.; Chua, R.; Swenson, C.; Tong, G. C.; Levi, E.;
Noy, N.; Hammerling, U. J. Exp. Med. 2000, 192, 835-846.
(11) Imam, A.; Hoyos, B.; Swenson, C.; Levi, E.; Chua, R.; Viriya, E.;
Hammerling, U. FASEB J. 2001, 15, 28-30.
(12) Breitman, T. R.; Takahashi, N. Biochem. Soc. Trans. 1996, 24, 723-
727.
(13) Myhre, A. M.; Takahashi, N.; Blomhoff, R.; Breitman, T. R.; Norum,
K. R. J. Lipid Res. 1996, 37, 1971-1977.
(14) Shealy, F. Y.; Frye, J. L.; Schiff, L. J. J. Med. Chem. 1988, 31, 190-
196.
(15) Wille, J. J.; Chopra, D. P. Cancer Lett. 1988, 40, 235-246.
(16) Hoyos, B.; Imam, A.; Korichneva, I.; Levi, E.; Chua, R.; Hammerling,
U. J. Biol. Chem. 2002, 277, 23949-23957.
(17) McClean, S. W.; Ruddel, M. E.; Gross, E. G.; DeGiovanni, J. J.; Peck,
G. L. Clin. Chem. 1982, 28, 693-696.
NP0496791